Status:
COMPLETED
A Randomized Triple-Blind Placebo-Controlled Study to Evaluate the Effects of a Supplement on Lower Urinary Tract Symptoms in Men.
Lead Sponsor:
Optimale
Collaborating Sponsors:
Citruslabs
Conditions:
Lower Urinary Tract Symptoms
Benign Prostatic Hyperplasia
Eligibility:
MALE
40+ years
Phase:
NA
Brief Summary
This study aims to evaluate the effects of the ProstaThrive™ supplement on lower urinary tract symptoms (LUTS) in men. It is a 90-day virtual, randomized, placebo-controlled trial with 80 male partici...
Detailed Description
This is a virtual two-arm randomized placebo-controlled clinical trial lasting 90 days. Participants will take the ProstaThrive™ supplement or a placebo daily and complete questionnaires at Baseline, ...
Eligibility Criteria
Inclusion
- Male participants aged 40+
- Experience symptoms such as frequent nighttime urination, incomplete bladder emptying, weak urinary stream, and frequent daytime urination
- Difficulty in getting or maintaining an erection
- Willing to avoid introducing any new products or medications targeting LUTS or erectile dysfunction during the study period
Exclusion
- Recent surgeries or invasive treatments
- History of prostate or male reproductive cancers
- Urinary issues caused by neurological conditions
- Previous surgery on the genitals, prostate, bladder, or urethra
- Known allergies to product ingredients
- Diagnosed with chronic health conditions impacting study participation
- Current substance abuse
- Participation in other clinical trials
- Taking medications or supplements targeting LUTS or erectile dysfunction
Key Trial Info
Start Date :
February 7 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 24 2024
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT06504472
Start Date
February 7 2024
End Date
June 24 2024
Last Update
July 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Citruslabs
Santa Monica, California, United States, 90404